halobetasol propionate and tazarotene
halobetasol propionate and tazarotene is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Duobrii. Available dosage form: lotion.
Drug Details
- Generic Name
- halobetasol propionate and tazarotene
- Brand Names
- Duobrii
- Application Number
- NDA209354
- Sponsor
- Bausch Health US, LLC
- NDC Codes
- 1
- Dosage Forms
- LOTION
- Routes
- TOPICAL
- Active Ingredients
- HALOBETASOL PROPIONATE, TAZAROTENE
Indications and Usage
1 INDICATIONS AND USAGE DUOBRII ® (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045% is indicated for the topical treatment of plaque psoriasis in adults. DUOBRII Lotion is a combination of halobetasol propionate and tazarotene indicated for the topical treatment of plaque psoriasis in adults. ( 1 )